Chad Terhune

Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.

Robert F. Kennedy Jr. faced questions from Congress about his own potential conflicts of interest during a confirmation hearing.

Dozens of scientists, researchers and other employees at the U.S. National Institutes of Health issued a rare public rebuke Monday criticizing the Trump administration for major spending cuts that “harm the health of Americans and people across the globe,” politicize research and “waste public resources.”

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with Reuters shows.

Dr. Ana Montanez is working overtime in Lubbock to contact vaccine-hesitant parents, explaining the grave risks posed by a disease that most American families have never seen, and one that can be prevented through immunization.

First there were the fast-moving, devastating fires. Now, amid the ruins of homes burned to the ground in the Los Angeles area blazes this month, workers are starting the massive, delicate task of removing hazardous debris as a prelude to rebuilding.

"Oh no. Hell no. That fire took everything out of me," said Karen Myles, 66. "I’m going to fly away somewhere, somewhere nice. Maybe Colorado."

As embers began raining down on Altadena last week, Jason Salit sent his wife and two college-age children away.

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the reimbursement available from private employers and insurers, according to an analysis shared with Reuters.

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims shared with Reuters.

Jul 10, 2024 ... Only one in four U.S. patients prescribed Novo Nordisk's Wegovy or Ozempic for weight loss were still taking the popular medications two ...

Jun 17, 2024 ... For many U.S. parents seeking help for a child with obesity, the most widely-endorsed treatment is out of reach - and it's not the popular ...

Dawn Heidlebaugh felt trapped in a disturbing pattern while taking Ozempic, the popular drug used to treat diabetes and obesity.

Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk’s Wegovy were still taking it a year later, while total healthcare costs for the group rose sharply, according to an analysis of U.S. pharmacy claims shared with Reuters.

Thousands of transgender U.S. youths are medically transitioning. The treatments they receive have little scientific evidence of long-term safety and efficacy.

More than 100,000 Americans died from diabetes in 2021, marking the second consecutive year for that grim milestone and spurring a call for a federal mobilization similar to the fight against HIV/AIDS.

Pharmaceutical giants marketed a treatment target they helped create, and as sales of diabetes drugs soared, so did dangerous incidents of low blood sugar.

The coronavirus pummeled Americans who have diabetes because when the pandemic hit, the nation was already fighting a losing battle against the chronic disease.

It took the deadly disruption of the COVID-19 pandemic to expose a deeper, more intractable U.S. public-health crisis: For more than a decade, the world’s richest nation has been losing the battle against diabetes.

After collecting billions of dollars in U.S. coronavirus aid, many of the nation’s wealthiest nonprofit hospitals are now tapping into disaster relief funds that critics say they don’t need.